Who
Alan Bruce Montgomery
Director
Company insider
Files Form 4 as: Director, Xencor; Director, Alder Biopharmaceuticals; Director, CytoDyn; Director, Zymogenetics; SVP, Respiratory Therapeutics, Gilead Sciences.
In numbers
- Trades disclosed
- 67
- Buys
- 1
- Sells
- 5
- Bought
- $30K
- Sold
- $581K
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 11 Sep 2006
- Last trade
- 16 Jun 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 8 Jul 2026 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —10,302 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —20,604 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —20,604 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —10,302 at $0.00 | filing |
| 15 Jun 2026filed 17 Jun 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $62K5,064 at $12.31 | filing |
| 15 Jun 2026filed 17 Jun 2026 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $62K5,064 at $12.31 | filing |
| 16 Jun 2025filed 16 Jun 2025 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $20K2,215 at $9.22 | filing |
| 12 Jun 2025filed 16 Jun 2025 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —27,372 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —13,686 at $0.00 | filing |
| 4 Dec 2024filed 4 Dec 2024 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code M | —991 at $0.00 | filing |
| 4 Dec 2024filed 4 Dec 2024 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code M | —430 at $0.00 | filing |
| 4 Dec 2024filed 4 Dec 2024 | XNCR XencorBiotechnology | SEC FORM 4 Code M | $15K991 at $15.35 | filing |
| 4 Dec 2024filed 4 Dec 2024 | XNCR XencorBiotechnology | SEC FORM 4 Code M | $8,600430 at $20.00 | filing |
| 4 Dec 2024filed 4 Dec 2024 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $38K1,421 at $27.03 | filing |
| 2 Dec 2024filed 4 Dec 2024 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code M | —5,008 at $0.00 | filing |
| 2 Dec 2024filed 4 Dec 2024 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code M | —8,293 at $0.00 | filing |
| 2 Dec 2024filed 4 Dec 2024 | XNCR XencorBiotechnology | SEC FORM 4 Code M | $127K8,293 at $15.35 | filing |
| 2 Dec 2024filed 4 Dec 2024 | XNCR XencorBiotechnology | SEC FORM 4 Code M | $100K5,008 at $20.00 | filing |
| 2 Dec 2024filed 4 Dec 2024 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $360K13,301 at $27.03 | filing |
| 27 Sep 2024filed 1 Oct 2024 | XNCR XencorBiotechnology | SEC FORM 4 Sold | $38K1,853 at $20.68 | filing |
News
No headline names them, or the companies they trade most, lately.